1. A Human Vascular Injury-on-a-Chip Model of Hemostasis
- Author
-
Lawrence F. Brass, Jeongyun Seo, Timothy J. Stalker, Keon Woo Kwon, Dongeun Huh, Izmarie Poventud-Fuentes, and Maurizio Tomaiuolo
- Subjects
Endothelium ,Context (language use) ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Fibrin ,Article ,Biomaterials ,In vivo ,Lab-On-A-Chip Devices ,medicine ,Humans ,General Materials Science ,Platelet ,Hemostasis ,biology ,Mechanism (biology) ,business.industry ,Thrombosis ,General Chemistry ,Vascular System Injuries ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,medicine.anatomical_structure ,biology.protein ,0210 nano-technology ,business ,Neuroscience ,Homeostasis ,Biotechnology - Abstract
Hemostasis is an innate protective mechanism that plays a central role in maintaining the homeostasis of the vascular system during vascular injury. Studying this essential physiological process is often challenged by the difficulty of modeling and probing the complex dynamics of hemostatic responses in the native context of human blood vessels. To address this major challenge, this paper describes a microengineering approach for in vitro modeling of hemostasis. Our microphysiological model replicates the living endothelium, multilayered microarchitecture, and procoagulant activity of human blood vessels, and is also equipped with a microneedle that can be actuated with spatial precision to simulate penetrating vascular injuries. The system recapitulates key features of the hemostatic response to acute vascular injury as observed in vivo, including i) thrombin-driven accumulation of platelets and fibrin, ii) formation of a platelet- and fibrin-rich hemostatic plug that halts blood loss, and iii) matrix deformation driven by platelet contraction for wound closure. Moreover, the potential use of this model for drug testing applications is demonstrated by evaluating the effects of anticoagulants and antiplatelet agents that are in current clinical use. The vascular injury-on-a-chip may serve as an enabling platform for preclinical investigation of hematological disorders and emerging therapeutic approaches against them.
- Published
- 2020